News
First patient dosed in Scancell’s clinical trial for multiple cancers
Scancell, a company which specialises in treating cancer and infectious diseases, has announced the enrolment and treatment of the first patient in its multicentre Modi-1 clinical trial (ModiFY) at Imperial College London, Hammersmith Hospital.